Anavex Life Sciences Corp. logo AVXL - Anavex Life Sciences Corp.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 11
HOLD 2
SELL 0
STRONG
SELL
0
| PRICE TARGET: $11.00 DETAILS
HIGH: $11.00
LOW: $11.00
MEDIAN: $11.00
CONSENSUS: $11.00
UPSIDE: 308.16%
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004
Revenue
Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Cost of Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Expenses
R&D Expenses 37.6 41.8 43.7 37.9 33.0 25.2 22.3 13.3 10.7 7.3 2.3 0.7 0.3 2.7 2.6 2.7 2.1 1.5 1.0 0 0 0
SG&A Expenses 13.8 11.0 12.0 13.1 9.0 5.9 6.8 6.0 5.0 8.3 4.8 2.2 1.9 1.7 3.6 2.9 2.6 3.8 0.6 0.0 0.1 0
Other Expenses 0 0 0 0 0 4.4 2.5 1.6 2.0 0.2 0 0.2 (1.0) 0 0 0 0 0 0 0 0 0
Operating Expenses 51.4 52.9 55.8 51.0 42.0 30.9 28.8 19.2 15.5 14.9 7.1 3.0 2.1 4.3 6.2 5.6 4.7 5.3 1.6 0.0 0.1 0.0
Operating Income
Operating Income (51.4) (52.9) (55.8) (51.0) (42.0) 0 0 0 0 0 0 0 0 (4.3) (6.2) (5.6) 0 (5.3) (1.6) (0.0) (0.1) 0
Interest Expense 0 0 1.0 0 0 0 0 0 0 0 0.1 0.0 0.1 0.1 0.1 0.3 0.1 0 0 0 0 0
Interest Income 4.7 7.3 6.5 0.9 0.0 0.2 0.2 0.3 0.1 0.0 0 0 0 0 0 0 0 0 0 0 0 0
Profitability
EBITDA (46.4) (43.0) (46.5) (47.6) (37.6) (31.1) (28.9) (19.1) (15.6) (15.0) (12.1) (11.6) (2.1) (0.5) (5.1) (2.8) (4.0) (5.3) (1.6) (0.0) (0.1) (0.0)
EBIT (46.4) (43.0) (46.5) (47.6) (37.6) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Income Before Tax (46.4) (43.0) (47.5) (47.6) (37.6) (26.3) (26.2) (17.4) (13.4) (14.7) (12.1) (11.4) (3.7) 0 0 0 0 0 0 0 0 0
Income Tax Expense 0 0 0 0.4 0.3 0.0 0.1 0.1 0.1 0.0 0 0 0 0 0 0 0 0 0 0 0 0
Net Income (46.4) (43.0) (47.5) (48.0) (37.9) (26.3) (26.3) (17.5) (13.5) (14.7) (12.1) (11.4) (3.7) (8.3) (7.3) (8.8) (5.5) (5.4) (1.6) (0.0) (0.1) (0.0)
Per Share Data
EPS (Basic) -0.54 -0.52 -0.60 -0.62 -0.54 -0.45 -0.54 -0.39 -0.33 -0.42 -0.65 -1.16 -0.46 -1.18 -1.16 -1.64 -1.09 -1.09 -0.33 -0.01 -0.02 -0.01
EPS (Diluted) -0.54 -0.52 -0.60 -0.62 -0.54 -0.45 -0.54 -0.39 -0.33 -0.42 -0.65 -1.16 -0.46 -1.18 -1.16 -1.64 -1.09 -1.09 -0.33 -0.01 -0.02 -0.01
Shares Outstanding 85.3 83.5 79.8 76.9 69.8 58.2 48.9 44.7 40.8 35.2 18.6 9.8 8.0 7.0 6.3 5.4 5.1 4.9 4.8 4.8 4.3 1.9
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2009 2008 2004
Current Assets
Cash & Cash Equivalents 102.6 132.2 151.0 149.2 152.1 29.2 22.2 22.9 27.4 9.2 0.4 0.0 0.0
Short-Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Receivables 0.8 2.4 2.7 3.2 9.1 4.8 2.6 1.9 0.0 0.1 0 0 0
Inventory 0 0 0 0 0.0 0 (2.6) 0 0 0 0 0 0
Other Current Assets 0.4 0.9 0.7 0.0 (0.0) 0 2.6 0 0 0 0.1 0 0
Total Current Assets 103.8 135.6 154.4 152.7 161.6 34.5 25.3 24.3 27.8 9.4 0.4 0.0 0.0
Non-Current Assets
Property, Plant & Equipment 0 0 0 0 0 0 0 0 0 0 0.0 0.0 0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Assets 0 0 3.4 3,546.7 0.0 5.3 0 0.1 0.1 0.1 0 0 0
Total Non-Current Assets 0 0 3.4 3,546.7 0.0 5.3 0 0.1 0.1 0.1 0.0 0.0 0
Total Assets 103.8 135.6 154.4 152.7 161.6 34.5 25.3 24.4 27.8 9.5 0.4 0.0 0.0
Current Liabilities
Account Payables 4.2 9.6 4.3 3.8 4.7 4.0 3.5 3.0 3.6 3.1 1.6 0.7 0
Short-Term Debt 0 0 0 0 0 0 0 0 0 0 2.5 1.6 0
Deferred Revenue 0.8 0.8 0 0.4 0.4 0 0 0 0 0.1 (4.1) 0 0
Other Current Liabilities 1.6 1.5 6.9 (0.0) 0 0 0 0 0 0.1 0 0 0
Total Current Liabilities 8.9 15.3 12.5 10.2 10.8 7.3 5.0 3.9 3.6 3.2 4.1 2.3 0.0
Non-Current Liabilities
Long-Term Debt 0 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0 0.2 0 0
Total Liabilities 8.9 15.3 12.5 10.2 10.8 7.3 5.0 3.9 3.6 3.2 4.3 2.3 0.0
Stockholders' Equity
Common Stock 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0
Retained Earnings (382.4) (336.1) (293.1) (245.6) (197.6) (159.7) (133.4) (108.9) (91.5) (78.0) (12.6) (7.1) (0.0)
Accumulated Other Comprehensive Income 0 0 0 0 0 0 0 0 0 0 (0.0) 0.1 0
Total Stockholders' Equity 94.9 120.3 141.9 142.5 150.8 27.2 20.3 20.5 24.3 6.3 (3.9) (2.3) 0.0
Total Liabilities & Equity 103.8 135.6 154.4 152.7 161.6 34.5 25.3 24.4 27.8 9.5 0.4 0.0 0.0
Debt Metrics
Total Debt 0 0 0 0 0 0 0 0 0 0 2.5 1.6 0
Net Debt (102.6) (132.2) (151.0) (149.2) (152.1) (29.2) (22.2) (22.9) (27.4) (9.2) 2.2 1.5 (0.0)
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2005 2004
Operating Activities
Net Income (46.4) (43.0) (47.5) (48.0) (37.9) (26.3) (26.3) (17.3) (13.5) (14.7) (0.1) (0.0)
Depreciation & Amortization 0 0 0 0 0 0 0 0 0 0.0 0 0
Stock-Based Compensation 11.5 9.4 16.4 18.4 8.2 4.9 6.4 5.5 4.1 5.1 0 0
Change in Working Capital (4.2) 2.8 2.5 5.4 (0.7) 0.1 1.3 (0.8) 0.4 0.6 0.0 0.0
Other Non-Cash Items 0 0 0.8 0 0 0 0.0 0 (0.1) (0.2) 0.0 0
Operating Cash Flow (39.0) (30.8) (27.8) (24.2) (30.4) (21.3) (18.5) (12.6) (9.0) (9.2) (0.1) (0.0)
Investing Activities
Capital Expenditure 0 0 0 0 0 0 0 0 0 0 0 0
Acquisitions 0 0 0 0 0 0 0 0 0 0 0 0
Purchases of Investments 0 0 0 0 0 0 0 0 0 0 0 0
Sales/Maturities of Investments 0 0 0 0 0 0 0 0 0 0 0 0
Other Investing Activities 0 0 0 0 0 0 0 0 0 0 0 0
Investing Cash Flow 0 0 0 0 0 0 0 0 0 0 0 0
Financing Activities
Net Debt Issuance 0 0 0 0 0 0 0 0 0 (0.0) 0 0
Stock Repurchased 0 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities (2.7) 0 0 (0.7) 0.0 (0.4) (0.1) (0.1) 0 0 0.0 0
Financing Cash Flow 9.4 12.0 29.7 21.3 153.2 28.4 17.8 8.1 27.3 3.1 0.0 0.0
Cash Position
Net Change in Cash (29.6) (18.8) 1.9 (3.0) 122.9 7.1 (0.7) (4.5) 18.3 (6.1) (0.0) 0.0
Cash at Beginning 132.2 151.0 149.2 152.1 29.2 22.2 22.9 27.4 9.2 15.3 0.0 0
Cash at End 102.6 132.2 151.0 149.2 152.1 29.2 22.2 22.9 27.4 9.2 0.0 0.0
Free Cash Flow (39.0) (30.8) (27.8) (24.2) (30.4) (21.3) (18.5) (12.6) (9.0) (9.2) (0.1) (0.0)
Key Metrics 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004
Income Statement
Revenue 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Income (51.4) (52.9) (55.8) (51.0) (42.0) 0 0 0 0 0 0 0 0 (4.3) (6.2) (5.6) 0 (5.3) (1.6) (0.0) (0.1) 0
Net Income (46.4) (43.0) (47.5) (48.0) (37.9) (26.3) (26.3) (17.5) (13.5) (14.7) (12.1) (11.4) (3.7) (8.3) (7.3) (8.8) (5.5) (5.4) (1.6) (0.0) (0.1) (0.0)
EPS (Diluted) -0.54 -0.52 -0.60 -0.62 -0.54 -0.45 -0.54 -0.39 -0.33 -0.42 -0.65 -1.16 -0.46 -1.18 -1.16 -1.64 -1.09 -1.09 -0.33 -0.01 -0.02 -0.01
Balance Sheet
Cash & Equivalents 102.6 132.2 151.0 149.2 152.1 29.2 22.2 22.9 27.4 9.2 0.4 0.0 0.0
Total Assets 103.8 135.6 154.4 152.7 161.6 34.5 25.3 24.4 27.8 9.5 0.4 0.0 0.0
Total Debt 0 0 0 0 0 0 0 0 0 0 2.5 1.6 0
Stockholders' Equity 94.9 120.3 141.9 142.5 150.8 27.2 20.3 20.5 24.3 6.3 (3.9) (2.3) 0.0
Cash Flow
Operating Cash Flow (39.0) (30.8) (27.8) (24.2) (30.4) (21.3) (18.5) (12.6) (9.0) (9.2) (0.1) (0.0)
Capital Expenditure 0 0 0 0 0 0 0 0 0 0 0 0
Free Cash Flow (39.0) (30.8) (27.8) (24.2) (30.4) (21.3) (18.5) (12.6) (9.0) (9.2) (0.1) (0.0)